|
Q1 FY2027
As of Jun 30, 2026
|
Q4 FY2026
As of Mar 31, 2026
|
Q3 FY2026
As of Dec 31, 2025
|
Q2 FY2026
As of Sep 30, 2025
|
Q1 FY2026
As of Jun 30, 2025
|
Q4 FY2025
As of Mar 31, 2025
|
Q3 FY2025
As of Dec 31, 2024
|
Q2 FY2025
As of Sep 30, 2024
|
Q1 FY2025
As of Jun 30, 2024
|
Q4 FY2024
As of Mar 31, 2024
|
Q3 FY2024
As of Dec 31, 2023
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||
| Current assets: | |||||||||||
| Cash and cash equivalents | |||||||||||
| Restricted cash | |||||||||||
| Accounts receivable, net | |||||||||||
| Inventories, net | |||||||||||
| Prepaid and other current assets | |||||||||||
| Total current assets | |||||||||||
| Long term assets: | |||||||||||
| Operating lease right-of-use assets | |||||||||||
| Deferred offering costs | |||||||||||
| Property and equipment, net | |||||||||||
| Other non-current assets, net | |||||||||||
| Total non-current assets | |||||||||||
| Total assets | |||||||||||
| Liabilities and STOCKholders’ DEFICIT | |||||||||||
| Current liabilities: | |||||||||||
| Trade payables | |||||||||||
| Accrued expenses | |||||||||||
| Trade finance facility | |||||||||||
| Convertible debt obligations | |||||||||||
| Short-term borrowings, net | |||||||||||
| Convertible note | |||||||||||
| Note payable - related party, current, net | |||||||||||
| Operating lease liabilities, current | |||||||||||
| Deferred revenue | |||||||||||
| Total current liabilities | |||||||||||
| Long term liabilities: | |||||||||||
| Note payable - related party, long-term, net | |||||||||||
| Line of credit from related parties, net | |||||||||||
| Operating lease obligations, long-term portion | |||||||||||
| Total liabilities | |||||||||||
| Stockholders’ deficit: | |||||||||||
| Series AA convertible preferred stock, $0.0001 par value, 1,800,000 shares authorized; Nil shares and 924,921 shares issued and outstanding as of March 31, 2026 and 2025, respectively | |||||||||||
| Common stock; $0.0001 par value; 100,000,000 shares authorized; 53,202,530 and 47,048,174 shares issued and outstanding as of June 30, 2026 and March 31, 2026, respectively | |||||||||||
| Additional paid-in capital | |||||||||||
| Accumulated other comprehensive loss | |||||||||||
| Accumulated deficit | |||||||||||
| Total stockholders’ deficit | |||||||||||
| Total liabilities and stockholders’ deficit |
Loading...
